Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse dermal angiomatosis.

Bradley K Draper1, Alan S Boyd

  • 1Division of Dermatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. draperclan@juno.com

Journal of Cutaneous Pathology
|September 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin.

The journal of allergy and clinical immunology. Global·2025
Same author

Extradigital Symplastic Glomus Tumor and Review of the Literature.

The American Journal of dermatopathology·2024
Same author

An erythematous nodule on the nose.

International journal of dermatology·2024
Same author

Acral keratosis with eosinophilic dermal deposits: A rare subtype of colloid milium.

Journal of cutaneous pathology·2022
Same author

Cutaneous dermatomycosis with concurrent <i>Paecilomyces lilacinus</i> and <i>Candida guilliermondii</i> in a patient with longstanding diabetes.

JAAD case reports·2021
Same author

Case Report: Infantile Urticaria as a Herald of Neonatal Onset Multisystem Inflammatory Disease With a Novel Mutation in NLRP3.

Frontiers in immunology·2021
Same journal

Blastic Plasmacytoid Dendritic Cell Neoplasm.

Journal of cutaneous pathology·2026
Same journal

Atypical Grover Disease Associated With Merkel Cell Carcinoma: A Novel Paraneoplastic Presentation.

Journal of cutaneous pathology·2026
Same journal

Profile of a Founder: Herbert Zachareus Lund.

Journal of cutaneous pathology·2026
Same journal

The National Resident Match Program Arrives in Dermatopathology: 15 Years of Resilient Advocacy by the American Society of Dermatopathology's Fellowship Training Program Directors' Committee.

Journal of cutaneous pathology·2026
Same journal

Evaluating Large Language Models for Melanocytic Lesion Pathology Report Interpretation.

Journal of cutaneous pathology·2026
Same journal

An Atypical Skin Presentation of Adult-Onset Still's Disease With Histological Description: A Case Report.

Journal of cutaneous pathology·2026
See all related articles

Diffuse dermal angiomatosis (DDA) is a benign vascular condition presenting as skin plaques. Early treatment of underlying peripheral vascular disease can promote DDA resolution.

Area of Science:

  • Dermatology
  • Vascular Biology
  • Pathology

Background:

  • Diffuse dermal angiomatosis (DDA) is an acquired vascular proliferation.
  • Clinically, DDA presents as violaceous, livedoid plaques with ulceration.
  • Histology shows interstitial CD31-positive endothelial cells without atypia or vasculitis.

Observation:

  • A case of DDA in a 53-year-old man with peripheral vascular atherosclerosis is presented.
  • The patient's DDA resolved after undergoing revascularization procedures.
  • This suggests a link between DDA and ischemic peripheral vascular disease.

Findings:

  • DDA is characterized by a diffuse proliferation of endothelial cells in the dermis.
  • The condition lacks features of malignancy or vasculitis.

Related Experiment Videos

  • Resolution of DDA was observed following treatment for peripheral vascular disease.
  • Implications:

    • Peripheral vascular atherosclerosis may be an underlying cause of DDA.
    • Revascularization can effectively treat DDA in patients with ischemic vascular disease.
    • This finding highlights the importance of addressing underlying vascular pathology for DDA management.